CNCecilie Nørregaard

Cecilie Nørregaard

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cecilie Nørregaard has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Grønhøj

    Department of Otorhinolaryngology, Head and Neck Surgery and Audiology Rigshospitalet University of Copenhagen Copenhagen Denmark

    2 shared publications
  • Christian von Buchwald

    Department of Otorhinolaryngology, Head and Neck Surgery and Audiology Rigshospitalet, University of Copenhagen Copenhagen Denmark

    2 shared publications
  • David Hebbelstrup Jensen

    Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark

    1 shared publication
  • David Jensen

    Department of Otorhinolaryngology, Head and Neck Surgery and Audiology Rigshospitalet University of Copenhagen Copenhagen Denmark

    1 shared publication
  • Elo Andersen

    Department of Oncology Herlev Hospital University of Copenhagen Copenhagen Denmark

    1 shared publication
  • Jakob Schmidt Jensen

    Department of Otorhinolaryngology, Head and Neck Surgery and Audiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

    1 shared publication

Latest Publications

  • Open Access

    Cause‐specific mortality in HPV+ and HPV− oropharyngeal cancer patients: insights from a population‐based cohort

    by Cecilie Nørregaard, Christian Grønhøj, David Jensen, Jeppe Friborg, Elo Andersen, Christian von Buchwald

    Identifying the causes of death in head and neck cancer patients can optimize follow‐up and therapeutic strategies, but studies in oropharyngeal squamous cell carcinoma (OPSCC) patients stratified by HPV status are lacking. We report cause‐specific mortality in a population‐based cohort of patients with OPSCC. Patients who had been diagnosed with OPSCC (n = 1541) between 2000 and 2014 in eastern Denmark were included in the study. Causes of death were collected through medical files and the Danish National Cause of Death registry. Deaths were grouped as (1) primary oropharyngeal cancer, (2) secondary malignancies, (3) cardiovascular and pulmonary disease, or (4) other/unspecified. The cumulative incidence of death and specific causes of death were determined using risk analysis. At follow‐up, 723 (47.5%) patients had died. The median time to and cause of death were determined: oropharyngeal cancer (n = 432; 1.00 year), secondary malignancies (n = 131; 2.37 years), cardiovascular and pulmonary causes (n = 58; 3.48 years), and unspecified causes (n = 102; 3.42 years). HPV/p16 status was the strongest predictor of improved survival across all causes of death. The only cause of death to decrease in incidence over the 2 years after treatment was death from OPSCC. HPV/p16 positivity was an independent factor for improved survival across all causes of death in patients with OPSCC. In addition, both HPV‐positive and HPV‐negative OPSCC patients faced high 5‐ and 10‐year mortality rates. Implementing secondary screening and prevention strategies for late toxicity and mortality are major goals in managing the treatment of these patients.


  • Open Access

    Incidence and survival of oropharyngeal cancer in Denmark: a nation-wide, population-based study from 1980 to 2014

    by Jakob Schmidt Jensen, David Hebbelstrup Jensen, Christian Grønhøj, Kirstine Kim Schmidt Karnov, Cecilie Nørregaard, Tina Klitmøller Agander, Lena Specht, Christian von Buchwald